Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: Potential role of choroid plexus in the pathogenesis of HIV encephalitis

被引:57
作者
Chen, HX
Wood, C
Petito, CK
机构
[1] Univ Nebraska, Sch Biol Sci, Beadle Ctr E318, Lincoln, NE 68588 USA
[2] Univ Miami, Sch Med, Dept Pathol, Miami, FL 33101 USA
关键词
HIV; choroid plexus; brain; viral sequences;
D O I
10.3109/13550280009091950
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Possible mechanisms of HIV transmission to the brain include direct viral infection of cerebral endothelium and hematogeneous dissemination of viral-infected lymphocytes and monocytes, Cerebrospinal fluid dissemination from a primary infection of choroid plexus (CPx) is an alternative mechanism supported by recent studies in our laboratory, We showed that HIV-infected asymptomatic patients as well as AIDS patients have HIV infection of the CPx; the cell types so infected included stromal monocytes and dendritic cells, To further explore the potential role of CPx in the pathogenesis of HIV encephalitis, we analyzed HIV sequences from brain, CPx, and spleen of four AIDS patients by extracting DNA from paraffin sections and amplifying the V3 region of the HIV env gene by PCR, Several different clones from each tissue were characterized. We found that viruses from the brain and spleen grouped into two distinct clusters, while viruses of the CPx contained viral strains that were a mixture of those found in the brain or spleen. Net charge analysis of the V3 tip region showed that the brain viral sequences had fewer positive charges than blood viral sequences, Our results support the hypothesis that CPx may he one of the sites where HIV-1 gains access to the brain from the blood and therefore contains viruses that are of both genotypes.
引用
收藏
页码:498 / 506
页数:9
相关论文
共 59 条
[1]
An Shu F., 1997, Archives d'Anatomie et de Cytologie Pathologiques, V45, P94
[2]
Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry [J].
Bagasra, O ;
Lavi, E ;
Bobroski, L ;
Khalili, K ;
Pestaner, JP ;
Tawadros, R ;
Pomerantz, RJ .
AIDS, 1996, 10 (06) :573-585
[3]
GENOMIC VARIATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) - MOLECULAR ANALYSES OF HIV-1 IN SEQUENTIAL BLOOD-SAMPLES AND VARIOUS ORGANS OBTAINED AT AUTOPSY [J].
BALL, JK ;
HOLMES, EC ;
WHITWELL, H ;
DESSELBERGER, U .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :867-879
[4]
PRIMARY STAGE OF FELINE IMMUNODEFICIENCY VIRUS-INFECTION - VIRAL DISSEMINATION AND CELLULAR TARGETS [J].
BEEBE, AM ;
DUA, N ;
FAITH, TG ;
MOORE, PF ;
PEDERSEN, NC ;
DANDEKAR, S .
JOURNAL OF VIROLOGY, 1994, 68 (05) :3080-3091
[5]
HUMAN-IMMUNODEFICIENCY-VIRUS AND THE BRAIN - INVESTIGATION OF VIRUS LOAD AND NEUROPATHOLOGIC CHANGES IN PRE-AIDS SUBJECTS [J].
BELL, JE ;
BUSUTTIL, A ;
IRONSIDE, JW ;
REBUS, S ;
DONALDSON, YK ;
SIMMONDS, P ;
PEUTHERER, JF .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (04) :818-824
[6]
The relationship between AIDS dementia complex and the presence of macrophage tropic and non syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid [J].
Brew, BJ ;
Evans, L ;
Byrne, C ;
Pemberton, L ;
Hurren, L .
JOURNAL OF NEUROVIROLOGY, 1996, 2 (03) :152-157
[7]
DEXTRAN SULFATE BLOCKS ANTIBODY-BINDING TO THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITHOUT INTERFERING WITH GP120-CD4 INTERACTIONS [J].
CALLAHAN, LN ;
PHELAN, M ;
MALLINSON, M ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1543-1550
[8]
CHAKRABARTI L, 1991, AM J PATHOL, V139, P1273
[9]
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS PRESENT IN THE CEREBROSPINAL-FLUID OF A MAJORITY OF INFECTED INDIVIDUALS [J].
CHIODI, F ;
KEYS, B ;
ALBERT, J ;
HAGBERG, L ;
LUNDEBERG, J ;
UHLEN, M ;
FENYO, EM ;
NORKRANS, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) :1768-1771
[10]
Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628